W Birkmayer. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralAmphetamine/therapeutic useAnimalsBrain Chemistry/drug effectsCatecholamines/metabolismClinical Trials as TopicCognition Disorders/chemically inducedConstipation/chemically inducedDihydroxyphenylalanine/administration & dosageDihydroxyphenylalanine/adverse effectsDihydroxyphenylalanine/pharmacologyDihydroxyphenylalanine/therapeutic useDopamine/analysisDrug SynergismFeeding and Eating Disorders/chemically inducedHallucinations/chemically inducedHumansHuntington Disease/drug therapyHydrazines/therapeutic useHypertension/chemically inducedInfusions, ParenteralInjections, IntravenousMonoamine Oxidase Inhibitors/pharmacologyMovement Disorders/chemically inducedNausea/chemically inducedNorepinephrine/analysisParkinson Disease/drug therapyParkinson Disease/metabolismSerotonin/analysisStimulation, ChemicalTime FactorsTremor/chemically inducedVomiting/chemically induced
Substances: See more » CatecholaminesHydrazinesMonoamine Oxidase InhibitorsSerotoninDihydroxyphenylalanineAmphetamineDopamineNorepinephrine
Year: 1971 PMID: 4254333
Source DB: PubMed Journal: Wien Klin Wochenschr ISSN: 0043-5325 Impact factor: 1.704